1. Home
  2. TREE vs VNDA Comparison

TREE vs VNDA Comparison

Compare TREE & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LendingTree Inc.

TREE

LendingTree Inc.

HOLD

Current Price

$25.91

Market Cap

376.5M

Sector

Finance

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$5.08

Market Cap

361.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TREE
VNDA
Founded
1996
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
376.5M
361.4M
IPO Year
2008
2005

Fundamental Metrics

Financial Performance
Metric
TREE
VNDA
Price
$25.91
$5.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$71.25
$14.90
AVG Volume (30 Days)
387.4K
635.3K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
443.31
N/A
EPS
1.90
N/A
Revenue
$1,117,324,000.00
$216,105,000.00
Revenue This Year
$19.03
$21.35
Revenue Next Year
$7.07
$37.40
P/E Ratio
$13.69
N/A
Revenue Growth
24.12
8.72
52 Week Low
$25.98
$4.27
52 Week High
$74.53
$9.91

Technical Indicators

Market Signals
Indicator
TREE
VNDA
Relative Strength Index (RSI) 30.37 42.97
Support Level N/A $4.94
Resistance Level $39.74 $5.55
Average True Range (ATR) 1.03 0.18
MACD 0.15 -0.03
Stochastic Oscillator 9.56 17.14

Price Performance

Historical Comparison
TREE
VNDA

About TREE LendingTree Inc.

LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: